Comparable results were also obtained when analysing cfDNA obtained from BRAF-mutant NSCLC patients, the most frequently co-mutated genes being TP53 (57%), EGFR (26%), KRAS (15%) and NF1 (15%). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.